Studies have demonstrated that fucoidan modulates the CXCL12/CXCR4 axis, exerting a dose-dependent inhibitory effect on Huh7 liver cancer cells by reducing CXCL12 expression (68). The gene discussed is CXCR4; the disease is liver cancer.